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We herein present a case report and literature review of dermatofibrosarcoma protuberans in the breast of a male
patient. A 27-year-old man presented with a painless lump in his right breast with areas of bluish skin discoloration.
The diagnostic work-up comprised clinical examination, ultrasonography, core biopsy, mammography, and magnetic
resonance imaging. After surgical excision, the preoperative diagnosis of dermatofibrosarcoma protuberans was proven
by pathological examination and immunohistochemistry. The patient was still free of recurrence 1 year after surgical
excision. This extremely rare case is, to the best of our knowledge, the fifth such case reported in the literature.
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Background
Dermatofibrosarcoma protuberans (DFSP) is a rare soft
tissue neoplasm that was identified for the first time by
Taylor in 1890 [1]. It was described in 1924 by Darier and
Ferrand [2] as a progressive recurrent dermatofibroma
and was later termed dermatofibrosarcoma protuberans
by Hoffmann in 1925 [3].
DFSP is a rare soft tissue sarcoma that represents less
than 5% of all soft tissue sarcomas occurring in adults
aged 30 to 40 years [1]. The incidence of DFSP is five
cases in every one million persons per year [4]. The most
common sites are the trunk and extremities [5]. DFSP of
the breast is extremely rare, especially in men. We herein
provide a case report and literature review of DFSP in a
male patient.Case presentation
A previously healthy 27-year-old Pakistani man presented
with a painless lump in his right breast that was first
noticed about 1.5 years previously. He initially noticed a
thickened patch of skin, which gradually increased in size
with areas of bluish discoloration. During the most recent* Correspondence: maltarakji@hmc.org.qa; KJunejo@hmc.org.qa
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unless otherwise stated.couple of months, however, this patch of skin had become
a lumpy swelling. The patient had no family history of
breast, prostate, or testicular cancer. He had no systemic
signs or associated weight loss.
The patient’s general physical examination was unre-
markable with the exception of his right breast, which
contained a 4 × 3 cm lump in the lower outer quadrant
that extended upward to the nipple. The lump was at-
tached to the overlying skin but freely mobile on the
underlying muscle. The skin over the tumor contained
telangiectatic patches (Figure 1). There were no palpable
axillary lymph nodes bilaterally.
Mammography and ultrasonography of the breast
showed a well-defined 35 × 27 mm hypoechoic lesion at
the 7 to 8 o’clock position in the right breast. The lesion
corresponded to the palpable nodule and showed in-
creased vascularity on ultrasound (Figures 2 and 3). Mag-
netic resonance imaging (MRI) of the breast showed a
lobulated 4.9 × 3.5 × 2.5 cm lesion with more intense sig-
nals on T1- and T2-weighted images than the muscle
tissue. A plateau was present on the time-intensity curve.
The lesion was graded as a Breast Imaging Reporting and
Data System (BI-RADS) IV lesion, but malignancy could
not be excluded (Figure 4). The left breast appeared nor-
mal. Bilateral normal axillary lymph nodes were present.
The patient underwent ultrasound-guided core biopsy of
the lesion. Histopathological examination showed markedal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The skin over the tumor contained telangiectatic patches. Figure 2 Mammography showed a mass in the right breast. The left
breast was normal.
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cells arranged into a tight storiform pattern (Figure 4).
Immunohistochemically, the cells were positive for CD34,
bc12, CD99, β-catenin, and vimentin. This morphology
was very suggestive of dermatofibrosarcoma. Staging
computed tomography and a bone scan showed no evi-
dence of visceral or bone metastasis.
The patient underwent wide local excision including
the nipple-areolar complex. The pectoralis major fascia
was excised along with the tumor. His postoperative
recovery was uneventful. The final histopathological
analysis revealed DFSD measuring 4.5 × 4.0 × 2.5 cm
(Figure 5), with adequate surgical margins of 2.5 to 3.0
cm. No evidence of neoplasia was seen in the marginal
skin or underlying fibroadipose tissue. The patient was
still free of disease 12 months after the procedure.
PubMed and Google Scholar were used to search
similar cases published in the literature. A search of
PubMed from 1990 to 2014 revealed 69 articles on
DFSP. Forty-one of these articles concerned DFSP of
women’s breasts, 24 concerned patients unaffected by
DFSP, and 2 concerned patients with DFSP not located
in the breast. Of all 69 articles, only 2 were case reports
of DFSP in a man’s breast. Reports of two additional
male patients with DFSP of the breast were found in asearch of Google Scholar during the same time period
(Table 1) [6-9].
Discussion
Primary breast sarcomas are rare mesenchymal tumors
accounting for 0.2% to 1.0% of all breast malignancies
[10] and less than 5% of all soft tissue sarcomas [11].
DFSP has an annual incidence of only 0.8 cases per mil-
lion people and typically presents in mid-adult life with
female predominance. DFSP may develop in patients of
all ages, but those aged 30 to 40 years are primarily af-
fected [1].
The most common sites of development of DFSP are
the trunk (42% to 72%) and extremities (16% to 30%)
[12]. However, Prabhu et al. reported rare sites including
the hand, gluteal region, head and neck region, toe,
vulva, and parotid gland. Localization in the breast is
very rare [9].
DFSP is a soft tissue tumor of low-degree malignancy
that arises in the dermis and spreads into the subcutane-
ous tissues and muscle [13]. DFSP has a low malignant
potential, representing more a slow growing, localized
‘benign’ entity, but in 5% of the cases, this only nominally
sarcoma undergoes sarcomatous transformation, and from
that point often, after serial insufficient surgical excisions
Figure 3 Ultrasound with power Doppler showed high vascularity of the mass.
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coma, often presenting with pulmonary metastases and
even causing death of the patient.
Histologically, it is distinctively composed of mono-
morphic spindle cells arranged in a storiform pattern.
Positive CD34 staining helps in the diagnosis [14]. Clin-
ically, the lesion presents as a firm area of the skin,
most commonly about 1 to 5 cm in diameter, with pink
or violet-red plaques; the surrounding skin may be tel-
angiectatic [15]. The tumors are generally fixed to the
dermis but move freely over the more deeply lying tissue.
However, they are often fixed to more deeply seated struc-
tures in advanced and/or recurrent cases [16]. DFSP tends
to exhibit an indolent growth pattern and is usually less
than 5 cm in size [17].
The morphology of the tumor requires a 3- to 4-cm
surgical margin, and so, in most of the cases, a plasticFigure 4 Magnetic resonance imaging showed intense enhancement of i
right breast.surgical reconstruction is mandatory. The reason for the
insufficient primary surgical care is often the fear from
technical wound closure not involving the reconstructive
plastic surgeon in the process.
Ultrasound exploration reveals an ovoid lesion with a
circumscribed or microlobulated margin in the dermis
or subcutaneous tissue, and the use of Doppler shows
hypervascularization of the affected area [16]. Mam-
mography reveals a dense lesion without fat or calcifica-
tion [18]. Magnetic resonance imaging may be helpful
to define the depth of infiltration of the tumor [18]. Fine
needle aspiration cytology has been recommended as
the first-line evaluation technique for superficial soft tis-
sue tumors [19].
According to the NCCN Clinical Practice Guidelines
in Oncology, the gold standard treatment is complete
surgical excision with appropriate reconstruction [20].ntravenous contrast with dye accumulation and washout in the
Figure 5 Astoriform spindle cell pattern was shown with hematoxylin and eosin staining, 200 ×.
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ommended for treatment because the local recurrence
rate is 20% to 50% in cases of incomplete resection [4]. An
unresectable lesion or resected lesion with a positive
margin should be treated with adjuvant radiotherapy.
Adjuvant radiotherapy can reliably reduce the local re-
currence rate and avoid the mutilation and functional
deficits caused by repeated surgery [21]. Chemotherapy
in the form of imatinib has also been tried with encour-
aging results. Similar radiotherapy was attempted in a
limited series, but the results did not favor its regular
use [9].
Long-term follow-up requires strict ultrasonographic
monitoring every 6 to 12 months with biopsy in cases of
suspected recurrence. The 5-year survival rate of pa-
tients with DFSP is higher than 99% [22].
Our literature search revealed only four other cases
of DFSP in the breast of a man. The mean age of these
patients was 36.2 years, and the mean tumor size was
4.6 cm. To the best of our knowledge, the present case
is the fifth.Table 1 Literature search
Authors Years Age Sex Size (cm) Side
Chen [7] 2009 41 Male 4.5 Right
Park [8] 2011 36 Male -- Right
Akhtar [6] 2012 22 Male 5 Left
Prabhu [9] 2014 55 Male 5 Left
Present case 2014 27 Male 4 RightConclusions
DFSP is a soft tissue sarcoma that very rarely de-
velops in the breast of male patients. The clinical
presentation includes a painless, gradually enlarging
nodule with a thickened patch of skin exhibiting tel-
angiectasia. The diagnosis is based on ultrasonography,
mammography, MRI, and fine needle aspiration cytology.
Surgical excision with wide margins may reduce the risk
of recurrence.
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